The present invention relates to compounds of formula (I) suitable for use as PPAR agonists. The present invention also relates to pharmaceutical compositions containing the compounds of the present invention, and methods for their use for treating one or more conditions, which include, but are not limited to, diabetes, nephropathy, neuropathy, retinopathy, polycystic ovary syndrome, hypertension, ischemia, stroke, spastic colitis, inflammation, cataracts, cardiovascular diseases, metabolic X syndrome, hyper-LDL cholesterolemia, dyslipidemia (including hypertriglyceridemia, hypercholesterolemia, mixed hyperlipi demyem and hypo-HDL-cholesterolemia), atherosclerosis, obesity and other disorders associated with lipid metabolism and complications of energy homeostasis.
展开▼
